An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Stevanato Group, a global leader in drug containment, drug delivery, and diagnostic solutions, will participate in the Bank of America Securities Healthcare Conference from May 14 to May 16, 2024. The Company will present on May 15, 2024, at 11:20 a.m. (PT). A live webcast will be accessible on the Company's website, with a replay available for 90 days.
Stevanato Group, leader mondiale nelle soluzioni di contenimento farmaceutico, distribuzione di farmaci e diagnostica, parteciperà alla conferenza sulla sanità di Bank of America Securities dal 14 al 16 maggio 2024. L'azienda presenterà il 15 maggio 2024 alle 11:20 a.m. (PT). Sarà possibile seguire la trasmissione in diretta sul sito web dell'azienda, con una replica disponibile per 90 giorni.
Stevanato Group, líder mundial en soluciones de contención de medicamentos, administración de fármacos y diagnóstico, participará en la Conferencia de Salud de Bank of America Securities del 14 al 16 de mayo de 2024. La compañía presentará el 15 de mayo de 2024 a las 11:20 a.m. (PT). Se podrá acceder a la transmisión en vivo a través del sitio web de la compañía, y estará disponible una repetición por 90 días.
제약 보관, 제약 전달, 진단 솔루션 분야의 세계적인 선두기업인 스테바나토 그룹은 2024년 5월 14일부터 16일까지 뱅크 오브 아메리카 증권 헬스케어 컨퍼런스에 참여할 예정입니다. 이 회사는 2024년 5월 15일 오전 11시 20분(PT)에 발표할 예정이며, 회사 웹사이트에서 생중계를 볼 수 있으며, 90일 동안 다시 볼 수 있는 서비스가 제공됩니다.
Le groupe Stevanato, leader mondial dans les solutions de contenance de médicaments, de livraison de médicaments et de diagnostic, participera à la conférence sur la santé de Bank of America Securities du 14 au 16 mai 2024. L'entreprise présentera le 15 mai 2024 à 11h20 (PT). Une webdiffusion en direct sera accessible sur le site web de l'entreprise, avec une rediffusion disponible pendant 90 jours.
Die Stevanato Group, ein weltweiter Marktführer in den Bereichen Medikamentenbehälter, Medikamentenverabreichung und diagnostische Lösungen, wird vom 14. bis 16. Mai 2024 an der Bank of America Securities Healthcare Konferenz teilnehmen. Das Unternehmen wird am 15. Mai 2024 um 11:20 Uhr (PT) präsentieren. Ein Live-Webcast wird auf der Webseite des Unternehmens zugänglich sein, mit einer Wiederholung, die 90 Tage verfügbar ist.
Positive
None.
Negative
None.
PIOMBINO DESE, Italy--(BUSINESS WIRE)--
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Bank of America Securities Healthcare Conference taking place from Tuesday, May 14, 2024 to Thursday, May 16, 2024.
The Company will present on Wednesday, May 15, 2024 at 11:20 a.m. (PT). A live webcast will be available on the Company’s website at www.stevanatogroup.com under the "Investors" section. A replay of the webcast will be available for approximately 90 days after the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.
founded in 1949, stevanato group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. it is comprised of two operational divisions: - pharmaceutical systems (ompi and balda brands): specialized in ready-to-use glass containers and bulk primary packaging (syringes, cartridges, vials and ampoules); high quality and high precision plastic solutions for diagnostic, pharmaceutical and medical device applications. - engineering systems (spami, optrel, innoscan and svm brands): specialized in glass forming technology, inspection systems, assembly, packaging machines and serialization solutions for the pharmaceutical industry. these two divisions enjoy a close, synchronous relationship, featuring daily exchanges which ensure that stevanato group has complete control over the entire production process, from purchasing the finest raw materials to offering exceptional after-sales customer service. the group also benefits from the sglab activ
